"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00072683
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT01558843
This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Hartford Hospital, Hartford, Connecticut, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Washington University School of Medicine
Other
Sodium Management in Patients With Acute Neurological Injury
Acronym: SANI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00072683
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT00201994
Brain Diseases, Cardiovascular Diseases
Gustav Carus, Dresden, Germany
View Trial DetailsNCT06781710
Demyelinating Diseases, Hyponatremia
Cologne, Germany
View Trial DetailsNCT01212211
Hyponatremia, Metabolic Diseases
Carentan, France
View Trial Details